Details for 2010012149

Up to date per 04.04.2026

Actions

Title / Product Name

Hybridpolypeptide mit auswählbaren Eigenschaften

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2010012149

EP Publication Number

2330124

E-Number

711915

Language

PCT Number

Publication Date

08.06.2011 A

25.02.2015 B1

Registration Date

25.02.2015

AT Publication Date

15.04.2015

Application Date

11.08.2006

Registration Number

Priorities

11.08.2005

201664

17.08.2005

206903

12.12.2005

301744

IPC

C07K 14/575 20060101AFI20140627BHEP

Maximum Duration of Protection

11.08.2026

Owner

Amylin Pharmaceuticals, LLC9360 Towne Centre Drive San Diego, CA 92121US

AstraZeneca Pharmaceuticals LP1800 Concord Pike Wilmington, DEUS

Representative

No representatives present

Inventor

Levy, Odile Estherc/o Amylin Pharmaceuticals, Inc. 9360 Towne Centre Drive San Diego, CA 92121US

Hanley, Michael R.c/o Amylin Pharmaceuticals, Inc. 9360 Towne Centre San Diego, CA 92121US

Jodka, Carolyn M.c/o Amylin Pharmaceuticals, Inc. 9360 Towne Centre San Diego, CA 92121US

Lewis, Dianac/o Amylin Pharmaceuticals, Inc. 9360 Towne Centre San Diego, CA 92121US

Soares, Christopher J.c/o Amylin Pharmaceuticals, Inc. 9360 Towne Centre San Diego, CA 92121US

Ghosh, Soumitra S.c/o Amylin Pharmaceuticals, Inc. 9360 Towne Centre San Diego, CA 92121US

D'Souza, Lawrencec/o Amylin Pharmaceuticals, Inc. 9360 Towne Centre San Diego, CA 92121US

Parkes, David G.c/o Amylin Pharmaceuticals, Inc. 9360 Towne Centre San Diego, CA 92121US

Mack, Christine M.c/o Amylin Pharmaceuticals, Inc. 9360 Towne Centre San Diego, CA 92121US

Forood, Behrouz Brucec/o Amylin Pharmaceuticals, Inc. 9360 Towne Centre San Diego, CA 92121US